Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| MEDP | CLUSTER | bearish | 5/10 | A cluster of insider selling at Medpace (MEDP) over the past week saw the CEO, CFO, and two directors sell a combined $1 | Aug 26, 2026 |
| TWST | CLUSTER | neutral | 4/10 | A cluster of insider sales at Twist Bioscience, totaling ~$2.50M over a week, with the CEO, CFO, COO, and other senior e | Aug 26, 2026 |
| ARDX | CLUSTER | neutral | 2/10 | Seven ARDX insiders, including the CEO and CFO, sold a total of $229K in open-market sales on August 21, 2026, all at $3 | Aug 26, 2026 |
| PGEN | CLUSTER | bearish | 4/10 | Precigen insiders show a mixed cluster: Director Nancy Agee made a small $25K open-market buy, while COO Rutul Shah sold | Aug 26, 2026 |
| ARDX | CLUSTER | neutral | 2/10 | Six ARDX insiders, including CEO Michael Raab and the Chief Commercial Officer, collectively sold $226K in open-market s | Aug 25, 2026 |
| PGEN | CLUSTER | neutral | 2/10 | Precigen (PGEN) insiders showed mixed activity in a 7-day cluster: Director Nancy Agee made a small open-market purchase | Aug 25, 2026 |
| OMER | CLUSTER | neutral | 3/10 | Two insiders at Omeros (VP of Finance and a Director) sold a combined $466K in open-market shares over two days, followi | Aug 25, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | CEO Martine Rothblatt and EVP Paul Mahon sold a combined $177K in open-market shares over a week, with Rothblatt also ex | Aug 25, 2026 |
| ELAN | CLUSTER | bullish | 6/10 | Elanco Animal Health insiders made $1.03M in net open-market purchases over the past week, led by Director Lawrence Kurz | Aug 25, 2026 |
| APLM | CLUSTER | bullish | 8/10 | Three C-suite insiders at Apollomics Inc. (APLM) collectively purchased $2.25M in open-market stock at $15.00/share over | Aug 25, 2026 |
| STLN | CLUSTER | neutral | 3/10 | Two insiders at Starling Oncology traded in opposite directions within a week: Director Brad Hively sold $1.95M worth of | Aug 25, 2026 |
| ETON | CLUSTER | bearish | 5/10 | Eton Pharmaceuticals CEO Sean Brynjelsen sold ~$6.1M worth of stock over three days (Aug 19-20), and CBO David Krempa so | Aug 25, 2026 |
| MEDP | CLUSTER | neutral | 4/10 | Three Medpace insiders, including the CEO and CFO, sold a combined $26.4M in open-market shares over two days. The CEO a | Aug 25, 2026 |
| KURA | CLUSTER | bullish | 6/10 | Kura Oncology CEO Troy Wilson purchased $1.24M in open-market shares at ~$12.39, while the Chief Legal Officer and Chief | Aug 25, 2026 |
| ABCL | CLUSTER | mixed | 5/10 | Two directors at AbCellera made open-market purchases totaling $681K, with the largest buy ($570K) occurring 13 days aft | Aug 25, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | CEO Martine Rothblatt and EVP Paul Mahon sold a combined ~$1.1M in open-market sales over two days. The CEO's sales foll | Aug 25, 2026 |
| APLM | CLUSTER | bullish | 8/10 | Three C-suite insiders at Apollomics Inc. (APLM) collectively purchased $2.25M of stock at $15.00/share over a 4-day win | Aug 24, 2026 |
| ARQT | CLUSTER | neutral | 2/10 | Three insiders at Arcutis Biotherapeutics sold a total of $198K in open-market sales over a 7-day window, with the large | Aug 24, 2026 |
| LQDA | CLUSTER | neutral | 4/10 | Two insiders at Liquidia Corp sold a combined $6.46M in open-market sales within a week of the company's Q2 2026 earning | Aug 22, 2026 |
| ARQT | CLUSTER | neutral | 2/10 | Two insiders at Arcutis Biotherapeutics sold a combined $170K in open-market sales over a week. Director Welgus Howard G | Aug 22, 2026 |
| ZLAB | CLUSTER | neutral | 2/10 | Two Zai Lab insiders — Director William Lis and CFO Yajing Chen — sold a combined $220K in open-market sales over an 8-d | Aug 22, 2026 |
| FDMT | CLUSTER | neutral | 3/10 | CEO David Kirn and CLO Scott Bizily sold a combined ~$683K in open-market sales after exercising stock options. The CEO' | Aug 22, 2026 |
| CAMP | CLUSTER | bearish | 4/10 | Two Camp4 insiders — Director Andrew Schwab and CSO Daniel Tardiff — sold a combined $223K in open-market sales on Augus | Aug 22, 2026 |
| TWST | CLUSTER | neutral | 4/10 | Four Twist Bioscience insiders, including CEO Emily Leproust and President/COO Patrick Finn, sold a total of $8.48M in s | Aug 22, 2026 |
| KURA | CLUSTER | bullish | 6/10 | Kura Oncology CEO Troy Wilson purchased $1.11M of stock on the open market at $11.12/share, while Chief Legal Officer Te | Aug 22, 2026 |
| TAK | CLUSTER | neutral | 2/10 | Two Takeda insiders — the President of R&D and the Chief Human Resources Officer — sold a combined $598K in open-market | Aug 22, 2026 |
| ELAN | CLUSTER | bullish | 4/10 | Two Elanco insiders — Director Lawrence Kurzius and GC/Corp Sec Shiv O'Neill — made open-market purchases totaling $1.03 | Aug 22, 2026 |
| MEDP | CLUSTER | neutral | 3/10 | A two-insider cluster at Medpace shows net selling of $4.69M, dominated by Director Fred B. Davenport Jr.'s open-market | Aug 22, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | CEO Martine Rothblatt and EVP Paul Mahon sold a combined ~$1.54M in open-market sales on August 20, 2026, following the | Aug 22, 2026 |
| PTCT | CLUSTER | neutral | 2/10 | Two insiders at PTC Therapeutics sold a total of $459K in open-market sales over a 7-day window. Director Michael Schmer | Aug 22, 2026 |